ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

11039	Companies
241963	Keywords
170392	Articles
130278	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 08/12/2026 at 18:00, 1 month 9 days ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.07.26
ABIVAX publie les informations relatives au nombre total de droits de vote et d'actions conformément aux réglementations en vigueur. Abivax est une société de biotechnologie au stade clinique axée sur le développement de traitements thérapeutiques

Droits De Vote Biotechnologie Abivax Traiements Thérapeutiques Régulation De L’organisme
PRESS RELEASE

published on 08/12/2026 at 18:00, 1 month 9 days ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.07.26
ABIVAX annonce le nombre d'actions et de droits de vote au 31/07/26 conformément à la réglementation financière. Siège social à Paris. Focus sur le développement clinique de phase 3 de son candidat médicament ABX464

Droits De Vote Actions Abivax Développement Clinique ABX464
BRIEF

published on 07/30/2026 at 22:10, 1 month 22 days ago

Abivax Advances with FDA on Obefazimod for Ulcerative Colitis

Abivax Obefazimod Ulcerative Colitis NDA Submission FDA Interaction
BRIEF

published on 07/30/2026 at 22:10, 1 month 22 days ago

Abivax reçoit un retour positif de la FDA pour l'obéfazimod

FDA Abivax Obefazimod Rectocolite Hémorragique Autorisation De Mise Sur Le Marché
BRIEF

published on 07/30/2026 at 22:10, 1 month 22 days ago

Abivax receives positive feedback from the FDA for obefazimod

FDA Abivax Obefazimod Ulcerative Colitis Marketing Authorization
BRIEF

published on 07/30/2026 at 22:10, 1 month 22 days ago

Abivax obtient des avancées auprès de la FDA concernant l'obefazimod pour le traitement de la colite ulcéreuse

Abivax Obefazimod Rectocolite Hémorragique Soumission D'un Accord De Confidentialité Interaction Avec La FDA
PRESS RELEASE

published on 07/30/2026 at 22:05, 1 month 22 days ago

Abivax annonce un retour positif de la FDA à l’issue de ses échanges pré-NDA concernant l’obéfazimod
Abivax annonce un retour positif de la FDA à l’issue de ses échanges pré-NDA concernant l’obéfazimod. La société se prépare à déposer sa première NDA d'ici fin 2026

FDA Abivax Obefazimod Rectocolite Hémorragique NDA
PRESS RELEASE

published on 07/30/2026 at 22:05, 1 month 22 days ago

Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
Abivax announces positive pre-NDA interaction with FDA for Obefazimod, on track for NDA submission by end of 2026, reinforcing potential in treating ulcerative colitis

FDA Abivax Obefazimod Ulcerative Colitis NDA Submission
BRIEF

published on 07/24/2026 at 09:51, 1 month 28 days ago

Sofinnova Partners crosses threshold in ABIVAX

Euronext Paris Voting Rights Abivax Threshold Crossing Sofinnova Partners
BRIEF

published on 07/24/2026 at 09:51, 1 month 28 days ago

Franchissement de seuil par Sofinnova Partners dans ABIVAX

Euronext Paris Droits De Vote Franchissement De Seuil Abivax Sofinnova Partners

Accesswire

Published on 09/21/2026 at 15:45, 6 hours 46 minutes ago

Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 8 hours 11 minutes ago

Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 8 hours 26 minutes ago

Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 8 hours 31 minutes ago

Dateline Files Motion to Resume Operations at Colosseum
Published on 09/21/2026 at 13:45, 8 hours 46 minutes ago

Nine Mile Metals DDH WD-26-11 Intersects 2 High Grade VMS Zones Over 27.6M Including 3.08% CU-EQ Over 10.70M, 3.27% CU-EQ Over 9.30M and 4.30% CU-EQ Over 5.0M

View all ACCESSWIRE

EQS Group

Published on 09/21/2026 at 22:05, 26 minutes ago

Abivax Presents Business Updates and First Half 2026 Financial Results
Published on 09/21/2026 at 22:05, 26 minutes ago

Abivax présente les dernières avancées de ses activités et ses résultats financiers du premier semestre 2026
Published on 09/21/2026 at 20:34, 1 hour 56 minutes ago

BRANICKS Group AG: Regular interest payment on EUR 400 million bond to be made as scheduled – Completion of maturity extension imminent
Published on 09/21/2026 at 19:00, 3 hours 31 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 14 septembre 2026 au 18 septembre 2026
Published on 09/21/2026 at 18:00, 4 hours 31 minutes ago

Cham Swiss Properties places bond of CHF 100 million

Les Echos

Published on 09/21/2026 at 18:19, 4 hours 11 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 14 au 18 septembre 2026
Published on 09/21/2026 at 18:19, 4 hours 11 minutes ago

Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 4 hours 29 minutes ago

Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 4 hours 45 minutes ago

WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 4 hours 45 minutes ago

WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026

View all LES ECHOS COMFI WIRE